These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7206403)

  • 21. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension.
    Morgan JM; Griffiths M; du Bois RM; Evans TW
    Chest; 1991 Mar; 99(3):551-6. PubMed ID: 1899817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
    Kieler-Jensen N; Lundin S; Ricksten SE
    J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension.
    Tayama E; Ueda T; Shojima T; Akasu K; Oda T; Fukunaga S; Akashi H; Aoyagi S
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):715-9. PubMed ID: 17704123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary hypertension in patients with systemic scleroderma with CREST-syndrome and without it].
    Karoli NA; Rebrov AP; Orlova EE
    Ter Arkh; 2004; 76(5):15-8. PubMed ID: 15230125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between cold and altitude exposure on pulmonary circulation of cattle.
    Busch MA; Tucker A; Robertshaw D
    J Appl Physiol (1985); 1985 Mar; 58(3):948-53. PubMed ID: 3980396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular reactivity and pulmonary hypertension in systemic sclerosis.
    Rozkovec A; Bernstein R; Asherson RA; Oakley CM
    Arthritis Rheum; 1983 Aug; 26(8):1037-40. PubMed ID: 6882479
    [No Abstract]   [Full Text] [Related]  

  • 27. The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.
    Hachulla E; de Groote P; Gressin V; Sibilia J; Diot E; Carpentier P; Mouthon L; Hatron PY; Jego P; Allanore Y; Tiev KP; Agard C; Cosnes A; Cirstea D; Constans J; Farge D; Viallard JF; Harle JR; Patat F; Imbert B; Kahan A; Cabane J; Clerson P; Guillevin L; Humbert M;
    Arthritis Rheum; 2009 Jun; 60(6):1831-9. PubMed ID: 19479881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hemodynamics of the lesser circulation in systemic arterial hypertension].
    Guazzi MD
    Cardiologia; 1985 Oct; 30(10):947-50. PubMed ID: 3842648
    [No Abstract]   [Full Text] [Related]  

  • 30. [Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance].
    Bonnet F; Matamis D; Lepresle E; Cabane J; Le Gall JR
    Nouv Presse Med; 1982 May; 11(20):1570-1. PubMed ID: 7048249
    [No Abstract]   [Full Text] [Related]  

  • 31. Pulmonary vascular overreactivity in systemic hypertension. A pathophysiological link between the greater and the lesser circulation.
    Fiorentini C; Barbier P; Galli C; Loaldi A; Tamborini G; Tosi E; Guazzi MD
    Hypertension; 1985; 7(6 Pt 1):995-1002. PubMed ID: 4077227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complement depletion prevents pulmonary hypertension and leukopenia in sheep extracorporeal membrane oxygenation.
    Wonders T; Huttemeier P; Berry D; Schuette A; Kong D; Watkins WD; Zapol WM
    Trans Am Soc Artif Intern Organs; 1983; 29():210-4. PubMed ID: 6673232
    [No Abstract]   [Full Text] [Related]  

  • 33. Alteration in pulmonary blood flow induced by cold exposure to the hand in progressive systemic sclerosis.
    Yamauchi K; Arimori S
    Jpn J Med; 1989; 28(4):506-9. PubMed ID: 2810923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary vasoconstrictor overreactivity in borderline systemic hypertension.
    Moruzzi P; Sganzerla P; Guazzi MD
    Cardiovasc Res; 1989 Aug; 23(8):666-73. PubMed ID: 2598222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of severe pulmonary hypertension in scleroderma.
    Nair DV
    Indian Heart J; 1967 Jan; 19(1):43-6. PubMed ID: 6044466
    [No Abstract]   [Full Text] [Related]  

  • 36. Primary pulmonary hypertension.
    Cherian G; Abraham MT; Uthaman CB; Sukumar IP; Krishnaswami S; Bhaktaviziam A
    Arq Bras Cardiol; 1982 Apr; 38(4):311-8. PubMed ID: 7168664
    [No Abstract]   [Full Text] [Related]  

  • 37. Humoral agent from calf lung producing pulmonary arterial vasoconstriction.
    Robin ED; Cross CE; Millen JE; Murdaugh HV
    Science; 1967 May; 156(3776):827-30. PubMed ID: 6022232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary hypertension associated wth scleroderma--a case report.
    Bector NP; Sharma TD; Gupta RK; Pahuja JK
    Indian J Chest Dis; 1971 Jan; 13(1):27-9. PubMed ID: 5560449
    [No Abstract]   [Full Text] [Related]  

  • 39. Risk assessment of systemic sclerosis-associated pulmonary arterial hypertension: cardiac index
    Hassan HJ; Naranjo M; Kazzi B; Housten-Harris T; Hsu S; Balasubramanian A; Simpson CE; Damico RL; Kolb TM; Mathai SC; Hassoun PM
    Eur Respir J; 2022 Sep; 60(3):. PubMed ID: 35896206
    [No Abstract]   [Full Text] [Related]  

  • 40. Does left heart disease cause most systemic sclerosis associated pulmonary hypertension?
    Coghlan G
    Eur Respir J; 2013 Oct; 42(4):888-90. PubMed ID: 24081754
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.